ESCORWIN INNOVATIONS PVT. LTD.
Lead Molecules, Pharmacogenomics: from Paper to Patient
Lead Molecules, Pharmacogenomics: from Paper to Patient
Visit EVENT-CALENDER
Next Webinar on CADD+ML: 22-Nov-2025 (Details)
(Running for 27-Oct-25) Applied ML & AI for CADD, Life Sciences & Data Science (30 Days) (Form) (Advertisement Details)
CIN: U21000UP2025PTC221194, GSTIN: 09AAICE8098B1ZC
Escorwin Innovation Pvt. Ltd. provides multi-dimensional platform for: Discovery, Computation, Validation, Publication, Copyright, Patent, Software, Cooked Data, and Knowledge Transfer.
Escorwin I.P.L. invites Researchers/ Scientists/ Academicians to transform innovations into ground realities.
Currently, Escorwin is working for Discovery/Design of Potential Small Molecules for multiple diseases; and also involves Pharmacogenomics for personalised observation for Cancer diagnosis.
Enquiry email: escorwininnovations@gmail.com
At Escorwin, we are reimagining how research happens. Science thrives when ideas flow freely, when expertise meets opportunity, and when innovation isn’t limited by structure. Escorwin was created to embody that vision a research unit built around collaboration, flexibility, and purpose, connecting scientists, partners, and innovators who are passionate about advancing discovery in the world of small molecules.
We operate at the intersection of chemistry, biology, and innovation, enabling the exploration, design, and development of small molecules that have the power to transform industries from pharmaceuticals and biotechnology to materials and energy. Our model is simple but disruptive: instead of building static research institutions, we bring together agile teams of researchers and collaborators who can rapidly assemble around a problem, execute with precision, and deliver meaningful outcomes.
Escorwin is designed for the way modern science should work modular, connected, and scalable. We offer on-demand research services, collaborative R&D projects, and specialized expertise that can be seamlessly integrated into your existing programs. Whether you’re a startup looking to accelerate proof-of-concept studies, a research lab seeking collaborative insights, or a company aiming to outsource specific discovery tasks, Escorwin provides the structure and scientific depth to make it happen efficiently.
What sets us apart is our networked approach to research. Our team is not confined to a single lab or institution instead, we leverage a broad ecosystem of researchers, collaborators, and technical partners. This allows us to tap into diverse expertise, cutting-edge tools, and emerging technologies while maintaining agility and cost efficiency. We believe that innovation accelerates when the barriers between disciplines and organizations are removed.
Our focus on small molecules reflects both our passion and our belief in their transformative potential. These molecular architectures continue to define the frontiers of therapeutic development, materials science, and chemical innovation. From structure-based design and synthetic optimization to analytical characterization and early biological evaluation, Escorwin’s collaborative model supports the full lifecycle of molecular discovery.
But beyond our science, Escorwin is a community of problem-solvers. We are driven by curiosity, collaboration, and a shared vision that meaningful research should be accessible, flexible, and impactful. Our platform allows partners to co-create, experiment, and innovate with confidence supported by transparent communication, adaptable workflows, and a commitment to scientific excellence.
At Escorwin, we don’t just conduct research; we assemble possibility. We empower organizations and individuals to pursue their scientific goals with the speed and creativity that modern innovation demands. Together, we’re building a new model for R&D — one that’s open, collaborative, and built for the future of science.
Escorwin: assembling innovations for one molecule at a time.
Our mission at Escorwin is to accelerate discovery in small-molecule science by connecting researchers, innovators, and organizations through a flexible, collaborative research ecosystem. We bridge the gap between imagination and implementation in small-molecule research. We aim to transform how R&D is done making high-quality, agile, and impact-driven research accessible on demand.